Carestream expanded its line of imaging agents with Kodak X-Sight Nanosphere Conjugates labeled with Streptavidin for both in vivo and in vitro applications, aiming to provide an effective means for life science researchers to detect biotinylated probes in fluorescent molecular biology research applications.
The new conjugates labeled with Streptavidin will be offered in four distinct wavelengths from ultraviolet (UV) to near infrared (near IR). They are designed to provide an incredibly bright platform for translating molecular imaging experiments from in vitroto in vivoapplications.
The Kodak X-Sight imaging agent family also includes KODAKX SIGHT Nanospheres and KODAKX-SIGHT Large Stokes Shift Dyes, which are also offered in a variety of conjugated forms. While the KODAKX-SIGHT Imaging Agents have been optimized for KODAK In-Vivo Imaging Systems and KODAK Image Stations, they are compatible with other commercially available digital imaging systems.
Kodak X-SightNanosphere Conjugates labeled with Streptavidin will be available in July.
July 09, 2024 
